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Background: Glycemic index (GI) and glycemic load (GL) have been investigated as etiologic factors for some
cancers, but epidemiological data on possible associations between dietary carbohydrate intake and esophageal
cancer are scant. This study examined the association between GI, GL, and other dietary carbohydrate components
and risk of adenocarcinomas and squamous cell carcinoma of the esophagus accounting for established risk factors.
Methods: We analyzed data from a population-based Australian case-control study (2002-05) comprising 299
adenocarcinoma (EAC), 337 gastro-esophageal junction adenocarcinoma (EGJAC), 245 squamous cell carcinoma
(ESCC), and 1507 controls sampled from a population registry. Dietary information was obtained using a 135-item
food frequency questionnaire (FFQ); GI and GL were derived from an Australian GI database. Multivariable logistic
regression models were used to derive odds ratios (ORs).
Results: All three case groups tended to have a lower intake of fiber, and significantly higher intake of fat, total energy,
and alcohol (ESCC only) compared to controls. GI was unrelated to all histological types. Higher GL was not associated
with risk of EAC and EGJAC, but was inversely associated with risk of ESCC (adjusted model, ptrend = 0.006), specifically
among men where we observed a 58% reduced risk of ESCC in the highest versus the lowest quartile. Increased intake
of total carbohydrates and starch was related to similarly large risk reductions of ESCC. Fiber intake was strongly and
inversely associated with risk of EAC, EGJAC and ESCC (all ptrend ≤0.001), indicating risk reductions of 28%-37% per
10 g/day.
Conclusions: This study suggests a reduced risk of esophageal SCC with higher GL level particularly in men, but
provides no evidence for the role of GI in the development of esophageal cancer. In addition, increased fiber intake
appears to be associated with lower risk of all histological types of esophageal cancer.
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Esophageal cancer is the eighth most common cancer
worldwide, and the sixth most common cause of death
from cancer [1]. The common histologic types of eso-
phageal cancer, adenocarcinoma (EAC), gastro-esophageal
junction adenocarcinoma (EGJAC) and squamous cell car-
cinoma (ESCC) represent different disease entities with
distinct risk factor patterns [2]. While smoking, alcohol
consumption and some dietary factors are the predomi-
nant risk factors for SCC, male sex, age, race, obesity and
obesity-related factors are the main risk factors for EAC
and EGJAC. Factors related to glucose metabolism and
energy balance have been implicated in the development
of a number of cancers [3,4] and glycemic index (GI) and
glycemic load (GL), both reflecting the metabolic effects
of dietary carbohydrates, have been examined as possible
etiologic factors [5-7]. The glycemic index ranks carbohy-
drate foods according to a standard food (usually glucose
or white bread) based on their postprandial blood glucose
response and blood insulin levels [5,8-10]. The glycemic
load combines the glycemic index value and the quantity
of carbohydrate (g) to quantify the overall estimated gly-
cemic effect of standard portion sizes of foods [8,11]. Per-
sistently high GI and GL intakes may lead to chronic
elevations in blood glucose concentrations, while hyper-
glycemia, type 2 diabetes, and hyperinsulinemia have been
implicated as potential risk factors for some cancers, in-
cluding cancers of the digestive tract [12-14]. Further, a
high-GI diet may increase cancer risk by modulating the
insulin-like-growth factor (IGF) axis [15,16]. Insulin re-
sistance and altered levels of IGF compounds have been
suggested to influence the healing of esophageal mucosal
injury and esophageal cell apoptosis [12].
Results from recent meta-analyses of observational
studies [6,13] on the association between GI or GL and
cancer risk, however, are mixed. Pooled risk estimates
from case-control and cohort studies combined indicate
a positive association between GI or GL and colorectal
cancer risk, but not in cohort studies alone, and notably,
no association with pancreatic or other digestive tract
cancers.
Epidemiological data on dietary carbohydrate intake and
esophageal cancer are scant [13,17]. Ecological data sug-
gest a strong correlation between carbohydrate consump-
tion and the incidence of EAC [7]. Over the past decade
two case-control studies observed slightly increased, but
statistically non-significant risks for EAC [18] and ESCC
[19] with higher level of GI or GL. A single prospective
study [20] found that higher GI, but not GL, was sig-
nificantly associated with elevated risk of esophageal
cancer (EAC and ESCC cases combined) among men
only. A succeeding analysis of the same cohort indicated
an increased risk of esophageal adenocarcinoma with high
intake of added sugars in men [21].None of these investigations examined different his-
tologic subtypes simultaneously to reveal any potential
associations arising from their different etiologies. We
therefore used data from a large population-based case-
control study to examine the association between GI,
GL, and other dietary carbohydrate components (total
carbohydrates, starch, total sugars, fiber) and risk of
EAC, EGJAC, and ESCC accounting for established risk
factors and exploring potential effect modifiers.
Patients and methods
Study population
We used data from an Australian population-based
case-control study of esophageal cancer (Australian
Cancer Study, ACS) and restricted the current analysis
to the group of patients who had histologically con-
firmed primary, invasive EAC, EGJAC or ESCC and a
population-based control group. Tumors were categorized
as ‘esophageal’ and ‘esophagogastric junction’ tumors ac-
cording to the WHO classification [22]. Full details on the
study design and recruitment have been published pre-
viously [23]. In brief, the patients (cases) were adults ages
18 to 79 years who had primary invasive carcinoma of the
esophagus (ICD-10 C15) diagnosed between July 1, 2002
(July 1, 2001 in Queensland) and June 30, 2005 in the
mainland states of Australia. Patients were recruited either
through major treatment centers or through state-based
cancer registries. Of 1,577 patients who were invited to
participate in the study, 1,102 returned a completed ques-
tionnaire (70% of all those invited; 35% of all eligible pa-
tients living or deceased). Seven of these patients were
deemed ineligible on pathology review and were excluded.
Potential controls were selected randomly from the
Australian Electoral Roll (enrolment is compulsory) within
5-year age groups and state of residence to match the
distribution of the case series. Women were intentionally
over sampled in the control group at all ages to accom-
modate their simultaneous enrolment in a parallel case-
control study of ovarian cancer [24]. Of 3,042 eligible
controls who were contacted, 1,580 (51%) returned com-
pleted questionnaires. For the present analyses, we ex-
cluded 152 cases and 47 control participants who did not
return the food frequency questionnaire (FFQ), 35 cases
and 5 controls with more than 10% of FFQ items missing,
and 27 cases and 21 controls whose estimated caloric in-
take was extreme (<700 or >4000 kcal), leaving a final
sample of 1,507 controls and 881 cases. The cases con-
sisted of 299 (M/F 271/28) EAC cases, 337 (M/F 289/48)
EGJAC cases, and 245 (M/F147/98) ESCC cases for
analysis. The study was approved by the human research
ethics committee of the QIMR Berghofer Institute of Me-
dical Research and all participating institutions (Additional
file 1: Table S1). All study participants provided informed
written consent to take part.
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Dietary information was obtained using a 135-item semi-
quantitative FFQ based on the instrument developed by
Willett et al. [25], but modified for use in Australia [26,27]
and validated against 12-days weighed food records
[28,29]. Assessment of our FFQ relative to the food re-
cords showed moderate correlation coefficients (r) of 0.45,
0.42, 0.53, and 0.39 for total carbohydrates, starch, total
sugars, and fiber respectively for all participants [28].
Cases were asked to report their usual frequency of con-
sumption in the year before their diagnosis or, if their diet
had changed in the last 6–12 months, their usual diet.
Controls were asked to report how often they consumed a
specified amount of each food item in the previous year.
Daily intake of energy (kcal/d), macronutrients and carbo-
hydrate components (g/d) was estimated using Australian
food composition tables as contained in NUTTAB2006
[30]. The sugar variable used was total sugars (g/d) which
includes dietary mono- and disaccharides (fructose, glu-
cose, sucrose, maltose, lactose, galactose) [30].
To calculate GL and GI, we used an Australian GI data-
base (FoodWorks: Professional Edition, 2007) that com-
piled GI values based on carbohydrate-containing food
items to reflect their blood glucose response. Data not
available in FoodWorks were supplemented with GI va-
lues obtained from tables compiled by Atkinson and co-
workers [31]. We calculated total dietary GL of a food
item by multiplying the amount of carbohydrate contained
in a specified serving size of the food by the quantity of
that food item consumed per day and its corresponding
GI value (using glucose as the reference food). We then
summed the values for all carbohydrate containing foods
reported on the FFQ to estimate total GL [31,32]. The
overall GI was calculated by dividing the total dietary GL
by the total available carbohydrate intake.
Covariates
Study participants provided detailed health and lifestyle
information via a self-administered questionnaire [24].
Participants were asked to report their height and weight
one year before diagnosis for cases and one year before
study recruitment for controls. BMI (last year) was cal-
culated as weight divided by height (kg/m2) and used as
a predefined categorical variable according to commonly
used definitions of overweight and obesity [33]. Number
of pack-years of tobacco exposure was derived by divi-
ding the number of cigarettes smoked daily by 20 and
multiplying by the total number of years smoked (never
smoked, <15, 15- < 30, ≥30 pack-years). Other known
risk factors included in the analysis were age (y, continu-
ous), sex (male/female), education (highschool or less,
trade/diploma, university), lifetime alcohol consumption
(abstainer, <0-6, 7-20, >21 standard drinks of 10 g alco-
hol units/week), recreational physical activity index (low,moderate, high level based on frequency and intensity of
activity per week) [34], use of aspirin or other non-
steroidal anti-inflammatory drugs (NSAIDs) in the last
5 years (never user, occasionally, <weekly, ≥weekly), symp-
toms of gastro-esophageal reflux 10 years before diagnosis
(never, occasionally, <weekly, ≥weekly), presence of dia-
betes type 2 (no/yes, self-reported), and the following
dietary factors: fruit intake (g/d), red and processed meat
(g/d), and energy intake (kcal/d).
Statistical analysis
We calculated the odds ratio (OR) and 95% confidence
interval (95% CI) associated with each dietary exposure
using multivariable unconditional logistic regression ana-
lysis. We combined the sexes for analysis due to small
numbers of female cases, especially for esophageal adeno-
carcinomas. All dietary variables were adjusted for total
energy intake using the nutrient residual method as de-
scribed by Willett [25] and log-transformed prior to calcu-
lation of the residuals. Participants were categorized into
sex-specific quartiles based on the distribution of GI, GL
and other dietary carbohydrates (total carbohydrates,
starch, total sugars, fiber) among the male or female con-
trols, respectively. The first model was minimally adjusted
for age and sex (data not shown). The final multivariable
model was additionally adjusted for other established risk
factors and other potential confounders relevant to each
subtype of esophageal cancer: education, BMI last year,
smoking (pack-years), lifetime mean alcohol consumption,
physical activity, NSAIDs, acid reflux symptoms in last
10 years (not for ESCC), presence of diabetes (not for
ESCC), and selected dietary factors. To test for linear
trend across categories, the median value in each quartile
was modeled as a continuous variable. Risk estimates from
multivariable adjusted models were slightly attenuated,
but not materially different from age and sex adjusted
models; therefore results from multivariable adjusted
models are presented only.
We conducted subgroup analyses to examine whether
the associations between GI, GL and dietary carbohydrates
were modified by sex, BMI (<25 and ≥25), smoking status
(ever/never), or current alcohol consumption (</>sex-
specific median g/d), red meat and saturated fat intake
(</>sex-specific median g/d), diabetes type 2 (yes/no, EAC
and EGJAC only), acid reflux symptoms (ever/never, EAC
and EGJAC only). The statistical significance of any ob-
served stratum differences was assessed by including a
cross-product term in regression models. We present sex-
stratified analysis for ESCC only in supplementary mate-
rial. Further, we conducted sensitivity analysis, using a) a
combined smoking variable derived from current smoking
status and pack-years, b) explored various energy adjust-
ments, c) omitted BMI from multivariable analysis for
EAC. All analyses were conducted using the SAS statistical
Table 1 Non-dietary and dietary characteristics of study participants, N = 2,388
Characteristics Controls EAC P valuea EGJAC P valuea ESCC P valuea
N = 1507 N = 299 N = 337 N = 245
Non-dietary factors
Age (y, mean, SD) 61 (12) 64 (10) <0.0001 63 (10) <0.0001 65 (9) <0.0001
Sex (%)
Female 34 9 <0.0001 14 <0.0001 40 0.06
Male 66 91 86 60
Educational level (%)
Highschool or less 40.9 46.5 0.0002 37.7 0.01 57.1 <0.0001
Trade/diploma 43.6 47.2 51.6 34.3
University degree 15.5 6.3 10.7 8.6
Body mass index (kg/m2, %) s
< 25 36.2 20.5 <0.0001 27.4 < 0.0001 55.5 <0.0001
25 - <30 43.3 42.7 39.2 30.4
≥ 30 20.5 36.8 33.4 14.1
Physical activity index (%)
Low 19.3 23.8 0.33 21.7 0.76 29.5 0.0003
Moderate 41.0 36.6 37.7 30.7
High 39.7 39.6 40.6 39.8
Cumulative smoking history
(pack-years, %)
Never smoked 44.7 25.1 <0.0001 24.3 < 0.0001 23.1 <0.0001
< 15 25.2 20.1 19.9 19.7
15-29.9 13.3 19.1 22.3 20.2
≥ 30 16.8 35.7 33.5 37.0
Lifetime alcohol consumption
(10 g alcohol units/wk) (%)
Abstainer 10.7 6.4 <0.0001 9.2 0.0004 12.7 <0.0001
> 0-6 drinks/wk 38.1 27.8 29.7 26.6
7-20 drinks/wk 31.9 36.6 33.5 20.9
≥ 21 drinks/wk 19.3 29.2 27.6 39.8
Reflux symptoms 10 years ago (%)
Never 43.1 21.5 <0.0001 29.7 <0.0001 46.0 <0.0001
Occasionally 30.5 13.5 16.1 13.0
< Weekly 14.5 22.6 22.6 13.0
≥ Weekly 11.9 42.4 31.6 28.0
NSAID use (%)
Never user 43.7 46.3 0.24 47.6 0.62 51.4 0.07
Occasionally 31.4 26.0 28.7 27.4
< Weekly 9.0 8.8 9.0 7.5
≥ Weekly 15.9 18.9 14.7 13.7
Presence of Diabetes (%)
No 93.0 87.6 0.002 88.2 0.02 95.8 0.09
Yes 7.0 12.4 11.2 4.2
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Table 1 Non-dietary and dietary characteristics of study participants, N = 2,388 (Continued)
Dietary factors(Mean, SD)b
Glycemic Indexc 51 (5) 52 (5) 0.38 52 (5) 0.16 52 (6) 0.17
Glycemic loadc 120 (23) 119 (22) 0.41 118 (22) 0.18 115 (25) 0.002
Total carbohydrates (g)c 234 (34) 231 (34) 0.14 229 (31) 0.01 221 (37) <0.0001
Total sugars (g)c 128 (35) 127 (33) 0.49 124 (33) 0.05 117 (38) <0.0001
Starch (g)c 101 (24) 98 (25) 0.04 99 (24) 0.28 94 (27) 0.001
Dietary Fiber (g)c 31 (9) 28 (8) <0.0001 27 (8) < 0.0001 28 (9) <0.0001
Protein (g) 93 (15) 91 (14) 0.25 92 (15) 0.29 89 (17) 0.003
Fat (g) 71 (12) 73 (12) 0.04 74 (11) 0.001 73 (13) 0.03
Saturated fat (g) 27 (7) 29 (7) <0.0001 30 (7) <0.0001 29 (7) 0.0005
MUFA (g) 25 (6) 25 (5) 0.65 26 (5) 0.02 25 (6) 0.67
PUFA (g) 11 (3) 10 (3) 0.002 11 (3) 0.48 11 (3) 0.80
Alcohol consumption (g)d 13 (16) 14 (16) 0.20 13 (17) 0.78 21 (24) <0.0001
Total Energy (kcal) 2215 (644) 2395 (729) <0.0001 2396 (700) <0.0001 2270 (795) <0.0001
% energy from CHO 45 (7) 45 (7) 0.23 45 (6) 0.03 43 (7) <0.0001
% energy from protein 18 (3) 18 (7) 0.06 18 (3) 0.08 17 (3) 0.003
% energy from fat 30 (5) 31 (5) 0.02 31 (5) <0.0001 31 (5) 0.03
ap-level chi-square test for categorical variables or chi-square test for trend, and t-test for continuous variables.
bdietary variables adjusted for energy intake (nutrient residual method), except for GI.
cMedian values for dietary exposure variables by sex (male/female controls): GI 52/50, GL 121/116, total carbohydrates 234/236 g/d, total sugars 123/132 g/d,
starch 100/100 g/d, dietary fiber 29/32 g/d.
dcurrent alcohol consumption (FFQ).
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tical tests were 2-sided with P-values <0.05 considered sta-
tistically significant.
Results
Study participants characteristics by subtype of esophageal
cancer are provided in Table 1. Overall, cases were pre-
dominantly male, with the highest proportion of women
(40%) among ESCC cases. Compared to controls, all 3
groups of cases tended to be older on average, were less
likely to have a university degree, more likely to be heavy
smokers (≥30 pack years) and heavy drinkers (≥21 drinks/
week, lifetime) and to have a low physical activity level
(ESCC only). As expected, the proportion of obese indi-
viduals among EAC (37%) and EGJAC (33%) cases, but
not ESCC (14%) cases, was substantially higher than
among controls (21%). Likewise, diabetes was more com-
mon among EAC and EGJAC cases (11-12%) compared to
their control counterparts (7%). Aspirin/NSAID use did
not differ significantly by case status. With regard to
dietary factors, all three groups of cases tended to have a
lower intake of fiber and protein (ESCC only), and higher
intake of total energy, total fat (g/day or % energy), satu-
rated fat, and for ESCC cases only, higher current alcohol
consumption (g/day) as compared to controls. Among
all study participants, vegetables (41%), fruit (28%), and
grains (23%) were the main food sources of dietary fiber
(% of total intake); grains (56%), vegetables (28%), andsweet snacks (10%) of starch; and fruit (36%), sweet snacks
(23%), dairy products (20%), and soft drinks (9%) of total
sugars.
Tables 2 and 3 present adjusted ORs for each subtype
of esophageal cancer according to intakes of GI, GL,
carbohydrate components and fiber for men and women
combined. GI and GL were not associated with risk of
EAC or EGJAC (Table 2), whereas higher GL was asso-
ciated significantly and inversely with risk of ESCC
(Table 3) in the fully adjusted model (ptrend = 0.006). We
observed a 48% reduced risk of ESCC in the highest
quartile compared with the lowest (reference) quartile.
GI was unrelated to risk of ESCC. In sensitivity analyses
(not shown), we additionally adjusted for fiber intake in
the multivariable models. Risk estimates were not ma-
terially different for any case group. Further, to test for
confounding or mediating effects of diabetes or BMI, we
conducted sensitivity analyses especially for adenocar-
cinomas (not shown). We excluded individuals with dia-
betes in each dietary exposure multivariable model, and
separately, for total sugars intake only, we omitted BMI
from the multivariable model. ORs were not significantly
changed in any of these analyses.
Total carbohydrate intake or selected carbohydrate
components were not related to risk of EAC and EGJAC
(Table 2). In contrast, mean intake of total carbohydrate
and starch was associated with similarly large risk reduc-
tions (54%) of ESCC (Table 3), when comparing highest
Table 2 Odds ratios and 95% confidence intervals for esophageal adenocarcinomas and gastro-esophageal junction
adenocarcinomas according to glycemic index, glycemic load, and dietary carbohydrate intakes, Australia 2002-2005
Controls EAC EGJAC
Multivariable modela Multivariable modela
N = 1490 N = 288 OR, (95% CI) N = 318 OR, (95% CI)
Glycemic Index (median, range)b
Q1: 46 (27-49) 374 67 1.00 69 1.00
Q2: 50 (49-51) 374 64 0.89 (0.59-1.36) 74 0.98 (0.67-1.45)
Q3: 53 (51-54) 368 80 0.91 (0.61-1.37) 94 1.07 (0.73-1.56)
Q4: 57 (54-71) 374 77 0.82 (0.54-1.26) 81 0.78 (0.52-1.18)
P-trendc 0.42 0.33
Per 10 unit/day increment 0.81 (0.58-1.12) 0.83 (0.61-1.13)
Glycemic Load (median, range)b
Q1: 95 (21-105) 373 74 1.00 82 1.00
Q2: 113 (105-120) 375 77 1.03 (0.69-1.54) 100 1.15 (0.80-1.65)
Q3: 126 (120-135) 371 77 0.88 (0.59-1.31) 68 0.75 (0.51-1.11)
Q4: 146 (135-259) 371 60 0.73 (0.48-1.13) 68 0.72 (0.49-1.08)
P-trendc 0.12 0.03
Per 50 unit/day increment 0.83 (0.60-1.16) 0.78 (0.57-1.07)
Carbohydrate (g/day) (median, range)b
Q1: 196 (94-212) 372 79 1.00 87 1.00
Q2: 224 (212-235) 375 82 1.14 (0.77-1.68) 97 1.21 (0.84-1.73)
Q3: 245 (235-256) 374 69 0.90 (0.59-1.38) 76 0.95 (0.64-1.40)
Q4: 273 (256-438) 369 58 0.79 (0.49-1.25) 58 0.75 (0.48-1.16)
P-trendc 0.21 0.13
Per 50 g/day increment 0.94 (0.74-1.21) 0.87 (0.69-1.09)
Starch (g/day) (median, range)b
Q1: 74 (31-85) 372 85 1.00 90 1.00
Q2: 93 (85-100) 374 73 1.00 (0.68-1.49) 79 0.90 (0.62-1.31)
Q3: 107 (100-116) 372 66 0.89 (0.59-1.33) 84 0.99 (0.69-1.43)
Q4: 128 (116-249) 372 64 0.80 (0.53-1.21) 65 0.71 (0.48-1.06)
P-trendc 0.25 0.17
Per 50 g/day increment 0.85 (0.63-1.16) 0.86 (0.64-1.14)
Total sugars (g/day) (median, range)b
Q1: 90 (25-106) 374 74 1.00 97 1.00
Q2: 116 (106-126) 371 71 1.10 (0.73-1.67) 84 1.01 (0.69-1.46)
Q3: 136 (126-148) 374 68 1.18 (0.76-1.84) 67 0.90 (0.60-1.34)
Q4: 168 (148-395) 371 75 1.22 (0.77-1.92) 70 0.88 (0.58-1.35)
P-trendc 0.38 0.47
Per 50 g/day increment 1.08 (0.85-1.36) 1.01 (0.81-1.27)
Fiber (g/day) (median, range)b
Q1: 21 (7-25) 371 106 1.00 122 1.00
Q2: 28 (25-30) 374 77 0.78 (0.54-1.14) 99 0.91 (0.65-1.27)
Q3: 33 (30-36) 372 58 0.63 (0.41-0.95) 68 0.63 (0.43-0.91)
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Table 2 Odds ratios and 95% confidence intervals for esophageal adenocarcinomas and gastro-esophageal junction
adenocarcinomas according to glycemic index, glycemic load, and dietary carbohydrate intakes, Australia 2002-2005
(Continued)
Q4: 41 (36-74) 373 47 0.49 (0.31-0.77) 36 0.34 (0.21-0.54)
P-trendc 0.001 <.0001
Per 10 g/day increment 0.72 (0.59-0.87) 0.63 (0.53-0.76)
aMultivariable Model: adjusted for age, sex, education, BMI, smoking (pack years), physical activity, lifetime mean alcohol intake, acid reflux symptoms in last
10 years, non-steroidal anti-inflammatory drug (NSAID) use, presence of diabetes, total fruit intake (except for fiber intake), red meat, processed meat, and
total energy.
bSex-specific quartile cut-off points are: glycemic index 47, 50, 53 for women and 49, 52, 55 for men; glycemic load 102, 117, 132 for women and 106, 121, 136 for
men; carbohydrate 215, 237, 259 for women and 211, 234, 255 for men; starch 85, 100, 114 for women and 85, 100, 117 for men; sugar 115, 132, 151 for women
and 102, 123, 145 for men; fiber 27, 32, 39 for women and 24, 29, 35 for men.
c Likelihood ratio test for trend across dietary variables quartiles by using an ordinal variable coded as the median value of the quartile.
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intake was strongly and inversely associated with risk of
EAC, EGJAC, and ESCC (all p trend <0.001). Specifically,
the cancer risk for each subtype was reduced between
28%-37% per 10 g/day increment of fiber intake (OR,
95%CI: EAC 0.72, 0.59-0.87; EGJAC 0.63, 0.53-0.76;
ESCC 0.64, 0.52-0.79).
To assess potential effect modification of the GI/GL-
esophageal cancer association by selected covariates, inter-
action terms for each glycemic/carbohydrate factor with
sex, BMI, smoking status or alcohol consumption were
tested. None of the tested interactions were statistically
significant with few exceptions. We observed that the
association between GL and ESCC was modified by sex
(p interaction = 0.02) presented in Figure 1. The inverse risk
pattern was confined to men only (OR, 95%CI; quartile 2:
0.48, 0.28-0.80; quartile 3: 0.34, 0.19-0.63; quartile 4: 0.42,
0.24-0.74), while no clear association became apparent
among women (OR, 95%CI; quartile 2: 1.13, 0.53-2.38;
quartile 3: 1.61, 0.77-3.39; quartile 4: 1.07, 0.50-2.32) as
shown in sex-specific Additional file 2: Table S2 and
Additional file 3: Table S3. Similar to GL, the carbo-
hydrates and starch associations differed by sex (total car-
bohydrates: p interaction = 0.02; starch: p interaction = 0.03).
The decreased risk of ESCC was accentuated in men only
(Additional file 2: Table S2 and Additional file 3: Table
S3). Further, we examined the potential effect modification
of the GI/GL/carbohydrate component-esophageal cancer
association by red meat intake and saturated fat intake
(data not shown). There was no evidence that these
dietary factors modified the association between GI
or GL and any subtype. For ESCC only, in stratified
analysis, the inverse total carbohydrates association
remained only among those with high red meat intake
(median split: >91 g/d, p trend = 0.0005), while the in-
verse fiber association was confined to those with low
fat intake (median split: <26.5 g/d, p trend <0.0001).
Discussion
In this large case-control study of Australian men and
women, GI was unrelated to risk of all histologic typesof esophageal cancer. GL was not associated with risk of
EAC and EGJAC, but was inversely associated with risk of
ESCC (30% risk reduction per 10 unit/d increment). This
dose-dependent association was independent of other es-
tablished risk factors, including smoking status, alcohol
consumption, BMI and selected dietary factors. Sex-
stratified analysis indicated that this association was con-
fined to men only. Similar to GL, higher intakes of total
carbohydrates and starch were significantly related to lo-
wered risk of ESCC. Total dietary fiber intake was in-
versely and strongly associated with all three tumor types
independent of sex (all p trend ≤0.001).
While published data on colorectal cancer suggest a
small to moderate increased risk with higher GI or GL
[6,13,20], findings derived from the few published re-
ports on esophageal cancer are not clear and reported
associations are of low magnitude. Results based on the
prospective National Institutes of Health (NIH)-AARP
Diet and Health Study [20] indicate that among men,
higher GI, but not GL, was associated with increased
risk of esophageal cancers (adenocarcinoma and squa-
mous cell carcinoma combined, 425 cases). Interestingly,
in stratified analyses, this association remained sig-
nificant only among smokers (former/current), men with
a high BMI, or high saturated fat intake. The FINBAR
case-control study [18] including 224 EAC cases (84%
men), showed a 42% increased risk per 10 unit higher GI
intake for this tumor type, and appeared to be stronger
(but not significantly) in centrally overweight individuals.
An earlier hospital-based case-control study [19] inclu-
ding 304 ESCC cases (90% men), suggested borderline
significant direct associations between GI (OR (95%CI)
1.1, 0.9-1.5, per 10-unit/d increment) or GL (1.2, 1.0-1.5,
per 100-unit/d increment) and ESCC risk.
Our observations made in the present study differ
from previous evidence in that glycemic indicators seem
to have a higher impact on risk of ESCC than on either
type of adenocarcinoma of the esophagus, and rather
GL, not GI, had a relevant effect on cancer risk. The lat-
ter finding supports the suggestion by Hu et al. [35] that
GL is a more physiologically relevant measure than GI
Table 3 Odds ratios and 95% confidence intervals for esophageal squamous cell carcinoma according to glycemic
index, glycemic load, and dietary carbohydrate intakes, Australia 2002-2005
Controls ESCC
Multivariable modela
N = 1490 N = 227 OR, (95% CI)
Glycemic Index (median, range)b
Q1: 46 (27-49) 374 60 1.00
Q2: 50 (49-51) 374 39 0.66 (0.41-1.05)
Q3: 53 (51-54) 368 58 1.01 (0.66-1.56)
Q4: 57 (54-71) 374 70 0.73 (0.46-1.14)
P-trendc 0.44
Per 10 unit/day increment 0.89 (0.66-1.21)
Glycemic Load (median, range)b
Q1: 95 (21-105) 373 85 1.00
Q2: 113 (105-120) 375 52 0.61 (0.40-0.92)
Q3: 126 (120-135) 371 48 0.67 (0.44-1.02)
Q4: 146 (135-259) 371 42 0.52 (0.33-0.82)
P-trendc 0.006
Per 50 unit/day increment 0.70 (0.50-0.97)
Carbohydrate (g/day) (median, range)b
Q1: 196 (94-212) 372 98 1.00
Q2: 224 (212-235) 375 58 0.81 (0.54-1.21)
Q3: 245 (235-256) 374 35 0.55 (0.35-0.87)
Q4: 273 (256-438) 369 36 0.46 (0.28-0.75)
P-trendc 0.0005
Per 50 g/day increment 0.72 (0.56-0.92)
Starch (g/day) (median, range)b
Q1: 74 (31-85) 372 91 1.00
Q2: 93 (85-100) 374 49 0.55 (0.36-0.84)
Q3: 107 (100-116) 372 44 0.52 (0.34-0.80)
Q4: 128 (116-249) 372 43 0.46 (0.29-0.71)
P-trendc 0.0003
Per 50 g/day increment 0.60 (0.43-0.82)
Total sugars (g/day) (median, range)b
Q1: 90 (25-106) 374 97 1.00
Q2: 116 (106-126) 371 35 0.54 (0.34-0.85)
Q3: 136 (126-148) 374 47 0.79 (0.51-1.23)
Q4: 168 (148-395) 371 48 0.83 (0.53-1.32)
P-trendc 0.59
Per 50 g/day increment 0.86 (0.68-1.09)
Fiber (g/day) (median, range)b
Q1: 21 (7-25) 371 93 1.0
Q2: 28 (25-30) 374 53 0.64 (0.43-0.97)
Q3: 33 (30-36) 372 45 0.45 (0.29-0.71)
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Table 3 Odds ratios and 95% confidence intervals for esophageal squamous cell carcinoma according to glycemic
index, glycemic load, and dietary carbohydrate intakes, Australia 2002-2005 (Continued)
Q4: 41 (36-74) 373 36 0.38 (0.23-0.63)
P-trendc <.0001
Per 10 g/day increment 0.64 (0.52-0.79)
aMultivariable Model: adjusted for age, sex, education, BMI, smoking (pack years), physical activity, lifetime mean alcohol intake, non-steroidal anti-inflammatory
drug (NSAID) use, total fruit intake (except for fiber intake), red meat, processed meat, and total energy.
bSex-specific quartile cut-off points are: glycemic index 47, 50, 53 for women and 49, 52, 55 for men; glycemic load 102, 117, 132 for women and 106, 121, 136 for
men; carbohydrate 215, 237, 259 for women and 211, 234, 255 for men; starch 85, 100, 114 for women and 85, 100, 117 for men; sugar 115, 132, 151 for women
and 102, 123, 145 for men; fiber 27, 32, 39 for women and 24, 29, 35 for men.
cLikelihood ratio test for trend across dietary variables quartiles by using an ordinal variable coded as the median value of the quartile.
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because of the narrow distribution of GI values (27-71,
median 52) in this study population which centered
around the middle of the theoretical range for GI (0-100),
we may have not been able to detect significant effects of
different levels of GI. This issue has also been raised by
other investigators [20,36]. Moreover, in contrast to the
NIH-AARP Diet and Health Study [20] we did not
observe any effect modification by smoking status (ever/
never), BMI (<25>), or saturated fat intake (median split) on
the GI/GL-esophageal cancer association (data not shown).
We have no straightforward explanation for the ob-
served moderate inverse association between GL and
ESCC risk which was observed only among men after
stratification by sex. It has been suggested that the direc-
tion and magnitude of glycemic indicators-cancer asso-
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Figure 1 Multivariable-adjusted odds ratios (ORs, CI 95%) of
esophageal squamous cell carcinoma (plotted on logarithmic
scale) are illustrated for men and women according to quartiles
of Glycemic Load (sex-specific quartile cut-off points: men 106,
121, 136; women 102, 117, 132).or high GL track with other dietary and lifestyle factors
related to cancer development [20]. For instance, in the
NIH-AARP cohort, high GL diets were inversely related
to total cancer only among adults with low BMI [20].
This is compatible with our finding of the inverse GL-
esophageal cancer association among ESCC cases only,
who on average have lower BMI than their counterparts
diagnosed with EAC or EGJAC as documented in this and
our previous studies [23,37]. Considering each tumor type
separately, however, the GI/GL-esophageal cancer asso-
ciation was consistent across all BMI levels; hence BMI
did not modify the relation between GI or GL and any of
the histologic types.
Higher fiber intake was associated with reduced risks of
all three tumor types in our investigation (28-37% risk re-
duction per 10-unit/d increment). This is in accordance
with other population-based case-control studies demon-
strating an inverse association between dietary fiber and
risk of EAC [18,38-42], EGJAC [40-42], and ESCC [40].
Based on our findings, no obvious heterogeneity of the
association between fiber and adenocarcinoma and squa-
mous cell carcinoma of the esophagus became apparent,
which is similar to one previous report [40], but contrasts
with another [41]. In the latter study total dietary fiber in-
take was significantly related to gastric cardia adenocar-
cinoma only. A recent meta-analysis on dietary fiber and
esophageal cancer risk, including a total of 10 population-
based or hospital-based case-control studies, also indicates
a more consistent inverse association for EAC than for
ESCC [43]. When exploring potential effect modification
by selected dietary factors, we observed that the inverse
fiber-ESCC association was confined to those individuals
with lower fat intake.
Fiber has a potential role in cancer prevention by
beneficially influencing blood glucose control, lipid pro-
files, and body weight [44-46]. Although the protective
mechanism of fiber is not well understood, it may act by
mechanical removal of carcinogens from food items that
pass through the digestive tract and/or removal of dam-
aged cells from the epithelial surface, by lowering plasma
levels of biomarkers of systemic inflammation, and by
reducing risk of hiatus hernia and gastro-esophageal re-
flux symptoms, or by mediating the glycemic response
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to overall carbohydrate intake, high fiber intake may be
a proxy for a diet rich in other bioactive constituents
(e.g. micronutrients) that are protective against cancer,
including esophageal malignancies.
Some limitations warrant consideration when interpre-
ting results of our study. A potential shortcoming was the
low participation rate among controls, which increases the
likelihood that our control sample was not representative
of the population from which the cases arose. To assess
the magnitude of possible bias, we compared smoking and
obesity prevalence in the control group with that reported
in the 2004 Australian National Health Survey (NHS)
[47]. The prevalence of ever-smoking and the distribution
of BMI in our study were similar to those in the NHS, and
using the NHS distributions to impute BMI values for
nonparticipating controls had minimal effect on risk
estimates [48]. Dietary measurement errors may have oc-
curred in our dietary assessment, including nondifferential
misclassification of exposure, and dietary recall bias re-
lated to cancer status, BMI and possibly other relevant
exposures all of which would attenuate effect estimates
[49,50]. It is likely that systematic error may be present
due to misreporting of energy- and macronutrient intake
by BMI status [51] specifically selective underreporting by
overweight women [52]. Other limitations include the
possibility of residual confounding from smoking, alcohol
consumption, and unmeasured variables. We have not
validated the assessment of GI or GL against an objective
standard or using a different dietary method. However,
average GI and GL intake values of female and male par-
ticipants in our study are compatible with dietary data
from other Australian studies assessed by FFQ [53,54] or
diet history interview [55].
Major strengths of our population-based study include
its large sample size, the examination of three different
but related esophageal cancer endpoints, a high case-
response rate, and the comprehensive control of other
risk factors.
Conclusions
In conclusion, this case-control study in Australian adults
suggests a reduced risk of esophageal SCC with higher GL
level, most notably among men, but provides no evidence
for the role of a high GI diet in the development of adeno-
carcinomas or squamous cell carcinomas of the esophagus.
Increased total fiber intake appeared to be comparably
protective for all histological types. This finding is in ac-
cordance with previous evidence from case-control studies
on esophageal cancers. Given the limited number of epi-
demiological studies on glycemic indicators and risk of
adenocarcinomas and squamous cell carcinoma of the
esophagus, it remains to be shown whether GI and/or GL
are meaningful predictors of these malignancies.Additional files
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